Apr 2026
PT Kalbe Farma Tbk (KLBF IJ/KLBF.JK)
1 1
YTD Dec 2025
Table of Contents
Key Updates 04
Business Strategies 09
Financial Overview 24
Appendix 1 30
Appendix 2 36
3
Key Updates
4
Key updates
Business Strategy
Financial Updates
Appendix I
Appendix II
More than Half a Century of Providing Wide-Range Healthcare SolutionsCorporate Overview
Establishment
1966IDX Listed
19917%
International
34.5%
Distribution &
Logistics
22.8%
Nutritionals
93%
Domestic
Prescription Pharmaceuticals
Net Sales 29.0%
IDR 35.3 tn
13.7%
Consumer Health
Market Capitalization*
IDR 46.11 tn |USD 2.71 bn
Free Float*
38.31%Treasury Shares*
3.34%*As of 31 Mar '26
Free FloaT is calculaTed as ToTal shares deducTed by The majoriTy, boards, Treasury and scripT shares
5
Key updates
Business Strategy
Financial Updates
Appendix I
Appendix II
Solid Fundamentals for Future GrowthKey Takeaways
8.3% 13.1%net sales growth net profit growth
Key Updates
Positive organic top-line growth driven by volume
Margin improvement Marketing investment to sustain growth
Progressing on track in key projects to drive future growth
Key Challenges
Pressure on purchasing power in domestic market Exchange rate fluctuation amidst geopolitics and trade war
Strategic Partnerships and Investments
Strengthening product portfolio
through collaboration
Established JV Livzon Pharma Indonesia to manufacture pharmaceuticals ingredients
Radiopharmaceuticals facilities
(cyclotron)
Biologic products' commercialization
Strategic Partnership with Alliance Pharma Co.,Ltd. to penetrate the Thai market
Moving towards local manufacturing of medical equipment
6